| Announce Date | 02/13/2026 |
| EPS Normalized Actual | $0.3641 (Beat by $0.0841) |
| EPS GAAP Actual | $0.3641 (Beat by $0.0841) |
| Revenue Actual | $0.614555B |
| Revenue Surprise | Beat by $614.555M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 3.10111 | 36.41 | 2.74067 | 3.54943 | 4 |
| Dec 2028 | 2.97632 | 37.93 | 2.77276 | 3.34824 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.0003 | -0.0003 | 0.614555B | -17.25% | 614.56M |
| FQ2 2025 (Jun 2025) | 0.74 | 0.74 | 0.877016B | 31.76% | 877.02M |
| FQ1 2025 (Mar 2025) | 0.16 | 0.16 | 0.789432B | 19.69% | 789.43M |
| FQ4 2024 (Dec 2024) | 0.31 | 0.31 | 1.18317B | 28.69% | 1183.17M |
| FQ3 2024 (Sep 2024) | 0.0165 | 0.0165 | 0.720596B | 20.19% | 720.6M |
| FQ2 2024 (Jun 2024) | 0.0828 | 0.0828 | 0.598458B | 19.46% | 598.46M |
| FQ1 2024 (Mar 2024) | -0.02 | -0.02 | 0.634B | -8.36% | 634M |
| FQ4 2023 (Dec 2023) | 0.18 | 0.18 | 0.843717B | 37.93% | 843.72M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 0.75309 | -- | 0.72789 | 0.79642 | 2 |
| FQ3 2028 (Sep 2028) | 0.75005 | -- | 0.72495 | 0.7932 | 2 |
| FQ2 2028 (Jun 2028) | 0.74701 | -- | 0.72201 | 0.78999 | 2 |
| FQ1 2028 (Mar 2028) | 0.74439 | -- | 0.71948 | 0.78722 | 2 |
| FQ4 2027 (Dec 2027) | 0.89579 | -- | 0.86581 | 0.94733 | 1 |
| FQ3 2027 (Sep 2027) | 0.77761 | -- | 0.75159 | 0.82235 | 1 |
| FQ2 2027 (Jun 2027) | 0.6171 | -- | 0.59645 | 0.65261 | 1 |
| FQ1 2027 (Mar 2027) | 0.69792 | -- | 0.69792 | 0.69792 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 0.62B | -- | 0.6B | 0.64B | 1 |
| FQ3 2028 (Sep 2028) | 0.62B | -- | 0.6B | 0.64B | 1 |
| FQ2 2028 (Jun 2028) | 0.62B | -- | 0.6B | 0.64B | 1 |
| FQ1 2028 (Mar 2028) | 0.62B | -- | 0.6B | 0.64B | 1 |
| FQ4 2027 (Dec 2027) | 0.65B | -- | 0.64B | 0.68B | 1 |
| FQ3 2027 (Sep 2027) | 0.65B | -- | 0.63B | 0.68B | 1 |
| FQ2 2027 (Jun 2027) | 0.65B | -- | 0.64B | 0.68B | 1 |
| FQ1 2027 (Mar 2027) | 0.54B | -- | 0.54B | 0.54B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.0003 | -0.0003 | 100% | |
| FQ2 2025 (Jun 2025) | 0.74 | 0.74 | 100% | |
| FQ1 2025 (Mar 2025) | 0.16 | 0.16 | 100% | |
| FQ4 2024 (Dec 2024) | 0.31 | 0.31 | 100% | |
| FQ3 2024 (Sep 2024) | 0.0165 | 0.0165 | 100% | |
| FQ2 2024 (Jun 2024) | 0.0828 | 0.0828 | 100% | |
| FQ1 2024 (Mar 2024) | -0.02 | -0.02 | 100% | |
| FQ4 2023 (Dec 2023) | 0.18 | 0.18 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0.61B | $614.56M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $0.88B | $877.02M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.79B | $789.43M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.18B | $1183.17M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.72B | $720.6M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.6B | $598.46M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.63B | $634M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.84B | $843.72M | 100% |